1. Introduction {#sec1-genes-11-00034}
===============

Human papillomaviruses (HPV) are double-stranded DNA viruses that exclusively infect the squamous epithelial layers of the mucosa and skin \[[@B1-genes-11-00034]\]. HPV can be transmitted between individuals via direct contact as well as through fomites, and HPV infection is considered to be the most common sexually transmitted disease on a global scale \[[@B2-genes-11-00034]\]. Moreover, a number of communicable as well as non-communicable diseases have been associated with HPV infection, including various types of warts and cancers \[[@B3-genes-11-00034]\]. Hundreds of HPV types have been identified and classified as either low-risk or high-risk depending on their likelihood upon infection to cause malignant or benign symptoms, respectively \[[@B4-genes-11-00034]\]. Due to their greater carcinogenic potential, the majority of HPV research has centered around high-risk types such as HPV 16 and 18 \[[@B5-genes-11-00034]\]. In contrast, low-risk HPV infection often manifests in the form of cutaneous warts in otherwise healthy individuals, although it can result in serious pathologies in immunocompromised populations \[[@B6-genes-11-00034]\].

Cutaneous warts are skin growths that can have different appearances depending on the type and location of HPV infection \[[@B7-genes-11-00034],[@B8-genes-11-00034]\]. Common warts, also referred to as *Verruca vulgaris*, are the most prevalent type of wart, constituting around 70% of all non-genital cutaneous warts \[[@B9-genes-11-00034],[@B10-genes-11-00034]\]. The wart itself is formed after HPV gains access to the basal layer of the epidermis via a microabrasion in the skin and induces the rapid growth and proliferation of keratinocyte cells \[[@B11-genes-11-00034]\]. In immunocompetent individuals, HPV-induced warts are self-limiting, as the virus is usually cleared from the body in a period of one to two years \[[@B12-genes-11-00034]\]. Over the course of the HPV life cycle, the viral genome undergoes dynamic changes in methylation patterns, an observation that has been tentatively attributed to the host's innate immune response \[[@B13-genes-11-00034]\]. In fact, HPV methylation is the initial trigger for the transformation of squamous epithelial cells, the latter of which undergo HPV-induced epigenetic re-programming \[[@B14-genes-11-00034]\]. However, the genetic mechanism of cutaneous wart formation is yet to be clearly elucidated, although their transient nature points towards the involvement of a regulatory epigenetic component such as methylation \[[@B15-genes-11-00034]\].

Cytosine methylation, which involves the post-replicative modification of CpG dinucleotides, plays a central role in epigenetic regulation by temporarily altering a gene's functional state \[[@B16-genes-11-00034]\]. In fact, methylation of CpG sites constitutes the majority of epigenetic modifications, and it is more pronounced in the gene body compared to the transcription promoter regions \[[@B17-genes-11-00034],[@B18-genes-11-00034]\]. While promoter methylation results in the silencing of gene expression, gene body methylation is associated with increased expression in dividing cells, and this contradiction, known as the DNA methylation paradox, is not well understood \[[@B19-genes-11-00034],[@B20-genes-11-00034],[@B21-genes-11-00034]\]. However, gene body methylation has been reported to be biologically advantageous as it inhibits the initiation of spurious transcription, the latter of which has undesirable pathological consequences in both lower and higher organisms \[[@B22-genes-11-00034],[@B23-genes-11-00034]\].

Maintaining tissue-specific methylation patterns is of great importance to the normal function of many biological processes, as aberrant methylation has been implicated in the tumorigenesis of several types of cancer \[[@B24-genes-11-00034],[@B25-genes-11-00034],[@B26-genes-11-00034]\]. Moreover, aberrant methylation patterns have been implicated in the carcinogenesis of cervical cancer and precancer specimens caused by high-risk HPV infection \[[@B13-genes-11-00034],[@B27-genes-11-00034],[@B28-genes-11-00034]\]. HPV-induced methylation of the host genome has been previously reported for high-risk HPV infection, but, to the best of the author's knowledge, there is a dearth of information on host methylation in cutaneous warts. In the current study, genomes from wart and normal skin samples were examined by means of a whole-genome tiling array for alterations in methylation profiles.

2. Materials and Methods {#sec2-genes-11-00034}
========================

2.1. Study Population and DNA Extraction {#sec2dot1-genes-11-00034}
----------------------------------------

Twelve Arab males presenting with HPV-induced warts were recruited at King Abdullah University Hospital (KAUH) in Irbid, Jordan. After obtaining informed consent, paired shave biopsies of the warts (*n* = 12) and nearby normal skin (*n* = 12) were performed by a resident dermatologist. The majority of biopsies were obtained from the hands (*n* = 20), while a few were taken from the forehead (*n* = 2) and foot (*n* = 2). A QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) was used to extract genomic DNA from the 24 tissue samples, and optional RNase A digestion was performed. DNA purity was determined on the BioTek PowerWave XS2 Spectrophotometer (BioTek Instruments, Inc., Winooski, VT, USA), while DNA integrity was ascertained through agarose gel electrophoresis. Samples were then shipped on dry ice to the Australian Genome Research Facility's (AGRF) Melbourne node for methylation profiling.

2.2. Infinium MethylationEPIC BeadChip {#sec2dot2-genes-11-00034}
--------------------------------------

At the AGRF, samples were subject to further quality control measures through assessment on the QuantiFluor^®^ dsDNA System (Promega, Gorman, NC, USA) and via 0.8% agarose gel electrophoresis. The 24 samples were then individually made up to approximately 500 ng of DNA in 45 μL, after which they were bisulfite converted by the Zymo EZ DNA Methylation kit (Zymo Research, Irvine, CA, USA). Finally, the samples were individually inputted into the Infinium MethylationEPIC BeadChip microarray (Illumina, San Diego, CA, USA) for interrogation of over 850,000 CpG sites.

2.3. Data Processing {#sec2dot3-genes-11-00034}
--------------------

A computational R package (RnBeads) was adapted to process and analyze the raw intensity data from the methylation chip in the form of IDAT files \[[@B29-genes-11-00034]\]. Quality control, preprocessing, batch effects adjustment, and normalization were carried out on all probes and samples according to the RnBeads package pipeline.

2.4. Differential Methylation and Statistical Analysis {#sec2dot4-genes-11-00034}
------------------------------------------------------

Differential methylation (DM) analysis was carried out based on tiling region, the latter of which is a genomic region of 5000 bp length. At the genome-tiling level, the mean of the mean β values (mean.mean β) of all the tested probes which span specified genomic regions were computed. The distribution of the number of CpG sites per genome tiling region can be seen in [Figure 1](#genes-11-00034-f001){ref-type="fig"}A. Additionally, [Figure 1](#genes-11-00034-f001){ref-type="fig"}B shows the distributions of CpG sites across genome-tiling regions. DM for each genome-tiling region was calculated using three measures: the mean.mean β difference between warts (W) and normal skin (NS); the log2 of the mean quotient in β means across all CpG sites in a genome-tiling region; and the adjusted combined *p*-value of all CpG sites in the genome-tiling region using a limma statistical test \[[@B30-genes-11-00034]\]. The Benjamini and Hochberg (B--H) 5% false discovery rate (FDR) was used to correct for multiple testing. Additionally, these three measures were used to give each genome-tiling region a combined rank, which was computed as the maximum (=worst) rank among the three ranks. Regions that exhibit more DM will have a smaller combined rank \[[@B29-genes-11-00034]\]. Genome-tiling regions were sorted from smallest to largest using the combined ranking score, then the best 1000 ranking regions were selected for further analysis.

2.5. Locus Overlap Analysis (LOLA) for Enrichment of Genomic Ranges {#sec2dot5-genes-11-00034}
-------------------------------------------------------------------

LOLA was carried out for the top 1000 genome-tiling regions, the latter of which were selected based on combined ranking score \[[@B31-genes-11-00034]\]. The following LOLA reference databases were utilized in the current analysis: cistrome_cistrome, cistrome_epigenome, codex, encode_segmentation, encode_tfbs, sheffield_dnase, ucsc_features. LOLA uses a Fisher's exact test to assess the significance of the overlap.

2.6. Signaling Pathway Analysis {#sec2dot6-genes-11-00034}
-------------------------------

A signaling network of the genes located in the top 100 most DM genome-tiling regions was created via the Signaling Network Open Resource 2.0 (Signor) \[[@B32-genes-11-00034]\]. The type of relation was selected to include 'all' interactions with a relaxed layout and a score of '0.0'.

3. Results {#sec3-genes-11-00034}
==========

3.1. Differential Methylation of Genome-Tiling Regions {#sec3dot1-genes-11-00034}
------------------------------------------------------

252,698 genome-tiling regions passed the quality control and pre-processing procedures. Notable differences were seen during the assessment of the methylation level (β) distributions for the genome-tiling regions in wart and normal skin samples ([Figure 2](#genes-11-00034-f002){ref-type="fig"}). The list of DM genome tiling in warts was limited to the top-ranking 1000 tiling regions using the combined ranking score. Using this scoring method, 772 and 228 tiling regions were found to be hypomethylated and hypermethylated, respectively, in warts compared to normal skin ([Figure 3](#genes-11-00034-f003){ref-type="fig"}A). Of the 772 hypomethylated tiling regions, the β difference ranged between −0.192 to −0.543, but it ranged between 0.192 and 0.472 in the 228 hypermethylated regions. The log~2~ of the quotient in methylation between warts and normal skin had a maximum value of 2.275 and a minimum value of −2.44 ([Figure 3](#genes-11-00034-f003){ref-type="fig"}B). The 100 genome-tiling regions with the lowest combined rank scores are presented in [Table 1](#genes-11-00034-t001){ref-type="table"} alongside their gene names.

3.2. Clustering of Samples {#sec3dot2-genes-11-00034}
--------------------------

Samples showed expected clustering based on all methylation values of the top 1000 most variable loci ([Figure 4](#genes-11-00034-f004){ref-type="fig"}). Samples sharing similar methylation patterns or phenotypes tended to cluster together. In addition, the dataset was subject to a dimension reduction test using multi-dimensional scaling (MDS) in order to inspect for a strong signal in the methylation values of the samples ([Figure 5](#genes-11-00034-f005){ref-type="fig"}). MDS confirmed that our analysis was dominated by differences between the wart and normal skin samples.

3.3. Locus Overlap Analysis (LOLA) for Enrichment of Genomic Ranges {#sec3dot3-genes-11-00034}
-------------------------------------------------------------------

The overall observation of enrichment and overlap across the LOLA reference databases for the hypermethylated and hypomethylated tiling regions are shown in [Figure 6](#genes-11-00034-f006){ref-type="fig"} and [Figure 7](#genes-11-00034-f007){ref-type="fig"}, respectively, while the details of the significantly enriched terms are shown in [Figure 8](#genes-11-00034-f008){ref-type="fig"} and [Figure 9](#genes-11-00034-f009){ref-type="fig"}, respectively. The top-ranking 1000 hypermethylated tiling regions show strong association with the Sheffield_dnase and encode_tfbs databases as indicated by the large odds ratio values. In addition to the strong association with the top tiling regions, encode_tfbs also exhibits a higher statistical significance overlap. From the encode_tfbs database, the c-Fos, STAT3, and c-Myc were among the most enriched terms. Using the Sheffield_dnase database, these tiling regions were predicted to be enriched in several cell and tissue types, including fibroblast cells, epithelial cells, muscle tissue, and skin tissue.

On the other hand, the top-ranking 1000 hypomethylated tiling regions show a strong association with Sheffield_dnase, ucsc_features, and codex indicated by the large odds ratio values, while cistrome_epigenome, encode_tfbe, and encode_segmentation exhibit statistical significance overlap with these tiling regions as indicated by the higher *q*-value. The most enriched terms include the Dnase weak-normal human dermal fibroblast (NHDF) cell line, Dnase-fibrobalsts, Weak Enhancer-human umbilical vein endothelial cells (HUVEC), nuclear receptor subfamily 2 group F member 2 (NR2F2)-Endometrial Stromal Cell, and monomethylation of Histone H3 at lysine 4 (H3K4me1)-lymph node carcinoma of the prostate (LNCaP) cell line.

3.4. Pathway Analysis {#sec3dot4-genes-11-00034}
---------------------

Signaling network analysis of the genes located in the top 100 DM genome-tiling regions illustrated that two genes, *ATF2* and *HDAC2*, were found to be common regulators of the gene network with a minimum of 12 connectivities each ([Figure 10](#genes-11-00034-f010){ref-type="fig"}).

4. Discussion {#sec4-genes-11-00034}
=============

Due to their benign nature, low-risk HPV and the cutaneous warts they induce have not been the subject of the same research attention and focus as their high-risk counterparts. In this study, a tiling array was carried out on paired samples of normal skin and warts from 12 Arab males. Methylation profiles were found to significantly differ between the cases and controls, and the top-ranking differentially methylated (DM) genes were mostly protein-coding (55%) and non-coding RNA (ncRNA) (11%) genes.

4.1. Aberrant Methylation of Protein-coding Genes {#sec4dot1-genes-11-00034}
-------------------------------------------------

Of the top-ranking 100 DM genes in warts compared to normal skin, 55 were protein-coding genes. The exocyst complex component 4 (*EXOC4*) gene was the most DM protein-coding gene in warts. Not much is known about *EXOC4* except that adjacent polymorphisms were associated with Type 2 diabetes \[[@B33-genes-11-00034]\]. However, *EXOC4* encodes a component of the exocyst complex, the latter of which is posited to be involved in viral protein transfer between cells \[[@B34-genes-11-00034]\]. As part of its infection process, HPV relies heavily on membrane-bound transport vesicles to deliver the viral material from the extracellular matrix to the host cell's nucleus \[[@B35-genes-11-00034],[@B36-genes-11-00034],[@B37-genes-11-00034]\]. The second most DM protein-coding gene is the potassium calcium-activated channel subfamily U member 1 (*KCNU1*) gene, which is a sperm-specific potassium channel that is essential for male fertility \[[@B38-genes-11-00034]\]. *KCNU1* might be important to HPV biology due to the fact that potassium channels are involved in cell proliferation and apoptosis, among other cellular processes \[[@B39-genes-11-00034]\]. The reticulon 1 (*RTN1*) gene was the third most DM protein-coding gene in warts, with previous reports showing that RTN1 deficiency and isoforms were associated with senile plaque formation and kidney disease progression, respectively \[[@B40-genes-11-00034],[@B41-genes-11-00034]\]. In the context of viral infection, deletion of *RTN1* in yeast cells led to a significant inhibition of viral replication \[[@B42-genes-11-00034]\].

Interestingly, several DM protein-coding genes, namely the *LGI1*, *IRF2*, and *NRG1* genes, have been implicated in squamous cell carcinoma, which involves the same keratinocyte layer that is exclusively hijacked by HPV infection. The leucine-rich glioma inactivated 1 (*LGI1*) gene is a putative suppressor of metastasis and, when downregulated, was found to stimulate esophageal squamous cell carcinoma metastasis \[[@B43-genes-11-00034]\]. Similarly, the interferon regulatory factor 2 (*IRF2*) gene, was reported to increase the tumorigenicity of esophageal squamous cell carcinoma when overexpressed \[[@B44-genes-11-00034]\]. Lastly, the neuregulin 1 (*NRG1*) gene, a cell adhesion molecule, was previously reported to be upregulated in oral squamous cell carcinoma cells \[[@B45-genes-11-00034]\]. It is important to understand the methylation profiles of benign warts so as to improve the understanding of the effects of low-risk HPV infection on host methylation, the latter of which has been extensively explored in the context of high-risk HPV infection.

Furthermore, various DM protein-coding genes in warts have been previously associated with cancers other than squamous cell carcinoma. Encoding an argonaute family protein, the piwi-like protein 4 (*PIWIL4*) gene was reported to be highly expressed in breast cancer cells, and its knockdown was found to lessen leukemic growth \[[@B46-genes-11-00034],[@B47-genes-11-00034]\]. Moreover, increased expression of the protein tyrosine phosphatase (*PTPRA*) gene and promoter methylation of the calcium-binding protein 39-like (*CAB39L*) gene were associated with gastric cancer \[[@B48-genes-11-00034],[@B49-genes-11-00034]\]. In addition, the abundant expression of the solute carrier family 22 member 16 (*SLC22A16*) gene, a carnitine transporter, has been reported in ovarian carcinoma cell lines, and its upregulation helped induce melanoma cell death when combined with chemotherapy \[[@B50-genes-11-00034],[@B51-genes-11-00034]\]. Likewise, the dimethylarginine dimethylaminohydrolase 1 (*DDAH1*) gene, which plays an integral role in methylarginine removal, was found to be frequently upregulated in prostate cancer \[[@B52-genes-11-00034]\], downregulated in gastric cancer \[[@B53-genes-11-00034]\], and inhibited in attenuated triple negative breast cancer cells \[[@B54-genes-11-00034]\]. In contrast, high expression of the Kelch-like family member 7 (*KLHL7*) gene, which encodes for a mediator of ubiquitination, is associated with aggressive breast cancer progression \[[@B55-genes-11-00034]\]. The fact that some protein-coding genes are DM in both warts and various HPV-associated cancers could potentially suggest that the extent of methylation contributes to whether the phenotype is malignant or benign.

4.2. Aberrant Methylation of Non-Coding Genes {#sec4dot2-genes-11-00034}
---------------------------------------------

Non-coding RNAs (ncRNAs) are non-protein coding RNA molecules that generally do not possess a known biological function, although a small minority have been identified as having important functional roles \[[@B56-genes-11-00034]\]. Dysregulated ncRNA expression patterns have also been implicated in HPV-associated cancers caused by high-risk HPV infection \[[@B57-genes-11-00034]\]. 11 of the top-ranking 100 DM genes in warts were non-coding RNAs (ncRNAs), including the most DM gene in warts, *AZIN1-AS1*. Very little is known about the AZIN1 antisense RNA 1 (*AZIN1-AS1*) gene both in terms of its function and disease associations. Likewise, the second and third most DM ncRNAs in warts were the long intergenic non-protein coding RNA 2008 (*LINC02008*) and the uncharacterized MGC27382 (*MGC27382*) genes. The *MGC27382* gene was previously reported to be a part of an endogenous RNA network that could serve as a prognostic biomarker for lung squamous cell carcinoma \[[@B58-genes-11-00034]\]. Moreover, *MGC27382* was found to be significantly upregulated in colorectal cancer but downregulated in lung adenocarcinoma \[[@B59-genes-11-00034],[@B60-genes-11-00034]\]. In addition, the long intergenic non-protein coding RNA 2241 (LINC02241) gene was the fourth most DM ncRNA in warts and was previously associated with hepatocellular and colorectal carcinomas \[[@B61-genes-11-00034],[@B62-genes-11-00034]\]. The fifth most DM ncRNA was the FER1L6 antisense RNA 1 (*FER1L6-AS1*) gene, which was found to be dysregulated in esophageal squamous cell carcinoma \[[@B63-genes-11-00034]\].

4.3. Genomic Hypermethylation {#sec4dot3-genes-11-00034}
-----------------------------

Hypermethylation of DNA has been associated with transcriptional silencing of the affected genes. From among ENCODE's transcription factor binding sites, the *c-Fos*, *STAT3*, and *c-Myc* genes were the most hypermethylated in warts ([Figure 7](#genes-11-00034-f007){ref-type="fig"}). The proto-oncogene *c-Fos* is involved in cell differentiation and proliferation, and its expression is required for skin tumors to become malignant \[[@B64-genes-11-00034]\]. Moreover, the induction of *c-Fos* expression promotes inflammation of the skin that, in turn, mediates the development of preneoplastic lesions \[[@B65-genes-11-00034]\]. On the other hand, *c-Fos* expression was found to decrease keratinocyte growth by increasing sensitivity to apoptosis, but this state was reversed upon the addition of c-Jun \[[@B66-genes-11-00034]\]. In high-risk HPV infection, skin tumorigenesis was found to be critically dependent on E2-induced *c-Fos* expression \[[@B67-genes-11-00034]\].

Similarly, the signal transducer and activator of transcription 3 (*STAT3*) gene is a transcription factor that is essential for cell apoptosis and growth \[[@B68-genes-11-00034]\]. In the skin, *STAT3* has a dual role in maintaining homeostasis and wound-healing as well as promoting carcinogenesis and psoriasis when aberrantly expressed \[[@B69-genes-11-00034],[@B70-genes-11-00034]\]. During periods of bacterial and viral infection, *STAT3* creates an inflammatory microenvironment that induces carcinogenesis \[[@B71-genes-11-00034]\]. *STAT3* activation is a common mechanism of herpesvirus pathogenesis, especially in the context of the varicella-zoster virus \[[@B72-genes-11-00034]\]. Additionally, autocrine *STAT3* activation is an integral part of HPV-mediated cervical cancer, and loss of *STAT3* expression is detrimental to high-risk HPV infection of keratinocytes \[[@B73-genes-11-00034],[@B74-genes-11-00034]\].

Lastly, the *c-Myc* gene is an oncogenic transcription factor that regulates the expression of 15% of the human genome and is dysregulated in the majority of human cancers \[[@B75-genes-11-00034]\]. In the mammalian epidermis, *c-Myc* overexpression helps stimulate keratinocyte proliferation, while *c-Myc* knockdown results in the latter's inhibition \[[@B76-genes-11-00034]\]. Alongside the SIN3 transcription regulator family member A (*SIN3A*) gene, *c-Myc* helps maintain tissue homeostasis in the skin, but epidermal cells deficient in c-Myc were found to be resistant to Ras-mediated tumorigenesis \[[@B77-genes-11-00034],[@B78-genes-11-00034]\]. Furthermore, *c-Myc* gene amplification was highly associated with infection by oncogenic high-risk HPV types in cervical carcinomas \[[@B79-genes-11-00034]\].

4.4. Genomic Hypomethylation {#sec4dot4-genes-11-00034}
----------------------------

In contrast to hypermethylation, hypomethylation of genomic DNA often leads to the activation of the affected genes. In warts, the *AR*, *NR2F2*, and *AFF1* genes were among the most significantly hypomethylated in warts compared to normal skin ([Figure 9](#genes-11-00034-f009){ref-type="fig"}). The androgen receptor (*AR*) gene, which is a nuclear receptor activated by androgenic hormones, normally functions as a DNA-binding transcription factor that is important in the development of male sexual characteristics \[[@B80-genes-11-00034]\]. Moreover, *AR* upregulation has been reported to suppress wound healing and increase inflammation in a murine model, and its dysregulation is involved in a number of different skin pathologies \[[@B81-genes-11-00034]\]. Loss of *AR* expression was reported to be a common event in intraepithelial neoplasia and invasive squamous cell carcinoma associated with high-risk HPV infection of the cervix \[[@B82-genes-11-00034]\].

Likewise, the nuclear receptor subfamily 2 (*NR2F2*) and the AF4/FMR2 family member 1 (*AFF1*) genes encode for nuclear transcription factors that play a critical role in vascular development and osteogenic differentiation, respectively \[[@B83-genes-11-00034],[@B84-genes-11-00034]\]. *NR2F2* inhibition by miR-302 contributes to somatic cell pluripotency, and its expression plays an important role in the chondrogenesis of mesenchymal stem cells \[[@B85-genes-11-00034],[@B86-genes-11-00034]\]. In addition, the *AFF1* gene was found to be downregulated in melanoma tissue and dysregulated in acute lymphoblastic leukemia \[[@B87-genes-11-00034],[@B88-genes-11-00034]\]. The involvement of the *NR2F2* and *AFF1* genes in HPV infection is still not clear.

4.5. Genes Involved in the Signaling Network Pathway {#sec4dot5-genes-11-00034}
----------------------------------------------------

Two genes, *ATF2* and *HDAC2*, were found to be common regulators of the top-ranking 100 most DM genes in warts ([Figure 10](#genes-11-00034-f010){ref-type="fig"}). Also known as cyclic AMP response element binding protein 2 (*CREB2*), the activating transcription factor 2 (*ATF2*) gene was found to be a common regulator of the DM gene network in HPV-induced warts. *ATF2* encodes a leucine zipper transcription factor that can also act as a histone acetyltransferase, and it has been implicated in various malignant skin diseases \[[@B89-genes-11-00034]\]. In fact, *ATF2* overexpression was necessary for tumor growth and progression in murine skin and for melanoma metastasis in human skin \[[@B90-genes-11-00034],[@B91-genes-11-00034]\]. On a similar note, the histone deacetylase 2 (*HDAC2*) gene, which encodes for an enzyme that deacetylates lysine residues situated within core histone N-terminal regions, plays an essential role in epidermal development \[[@B92-genes-11-00034]\]. *HDAC2* inhibition was found to stabilize tumor suppression and induce apoptosis in human keratinocyte cells infected with high-risk HPV \[[@B93-genes-11-00034]\].

4.6. Anatomical Location of Warts {#sec4dot6-genes-11-00034}
---------------------------------

In the present study, most of the warts were obtained from the hands (*n* = 20), with a minority taken from the feet (*n* = 2) and forehead (*n* = 2). Anatomic site is an important factor to consider in such studies, as it can influence the expression and methylation of genes. The hands and forehead, for example, are exposed to environmental factors that other parts of the body are not, leading to differences in gene expression between exposed and non-exposed skin \[[@B94-genes-11-00034]\]. Interestingly, in a cancer context, one study reported a novel epigenetic signature of HPV infection that was independent of the anatomic location in HPV-associated head and neck squamous cell carcinomas \[[@B95-genes-11-00034]\].

5. Conclusions {#sec5-genes-11-00034}
==============

Wart formation was found to involve a clear methylation pattern that sets it apart from normal skin. It was demonstrated that most differentially methylated genes were protein coding and included non-coding RNA genes as well. Surprisingly, many of the DM genes found in benign warts were previously reported to be involved in high-risk HPV infection and HPV-associated malignancies. The main limitation of the present study was that the participants were all male, but only males were included in order to minimize any genetic variation that might occur due to differences in sex.

The authors are grateful to all the participants of this study for their invaluable contributions. The authors would also like to express their gratitude to King Khalid University, Saudi Arabia for providing administrative and technical support.

L.N.A.-E. designed the method study and supervised the study. L.N.A.-E., A.H.T. and F.A.A.-Q. are responsible for samples and clinical data collections. L.N.A.-E., M.A.A. and A.H.T. lead the implementation of the method and performed the data analysis. L.N.A.-E., M.A.A. and A.H.T. helped with the interpretation, description of the results, and drafted the manuscript. All authors have read and agreed to the published version of the manuscript.

This work was supported by the Deanship of Research at Jordan University of Science and Technology under grant number 184/2017.

The authors declare no conflict of interest.

![Distributions of CpG sites (**A**) per genomic tiling region and (**B**) across genomic tiling region. In Panel B, the relative coordinates of 0 and 1 correlate to the start and end coordinates of the genomic tiling region. Those coordinates that are smaller than 0 and larger than 1 indicate flanking regions normalized by region length.](genes-11-00034-g001){#genes-11-00034-f001}

![Comparisons of the density distributions of methylation levels (β) in warts (W) and normal skin (NS).](genes-11-00034-g002){#genes-11-00034-f002}

![For the 1000 most differentially methylated tiling regions, scatterplot (**A**) and (**B**) volcano plot analyses were performed. In panel A, the mean of mean methylation levels (β) for warts (W) is on the y-axis, while the mean of mean methylation levels (β) for normal skin (NS) is on the x-axis. β values range from unmethylated (0) to methylated (1). In panel B, the volcano plot shows the differential methylation of genomic tiling regions as quantified by log~2~ of the mean quotient in means across all sites in a region on the x-axis and the adjusted combined p-value on the y-axis between warts (W) and normal skin (NS). The color scale corresponds with the combined rank of each genomic tiling region.](genes-11-00034-g003){#genes-11-00034-f003}

![Heatmap showing the hierarchical clustering of samples displaying only the 1000 most variable loci with the highest variance across all samples. Clustering used complete linkage and Manhattan distance. Patient identification number is shown on the bottom *x*-axis. The normal skin (NS) and wart (W) samples are shown on the top *x*-axis. Values of 0 (red color) and 1 (purple color) indicate decreased and increased methylation, respectively.](genes-11-00034-g004){#genes-11-00034-f004}

![Scatter plot showing samples after performing Kruskal's non-metric multidimensional scaling based on the matrix of average methylation levels and Manhattan distance.](genes-11-00034-g005){#genes-11-00034-f005}

![Scatterplot of LOLA enrichment analysis showing the effect size (log-odds ratio) versus the significant *q*-value (−log10 (*q*-value)) of the 1000 most hypermethylated tiling regions. These regions show strong association and significant overlap with Sheffield_dnase and encode_tfbs as indicated by the large odds ratio and higher *q*-value. LOLA reference databases collections are shown on the right side of the plot with color coding.](genes-11-00034-g006){#genes-11-00034-f006}

![Scatter plot of LOLA enrichment analysis showing the effect size (log-odds ratio) versus the significant *q*-value (−log10 (*q*-value)) of the 1000 most hypomethylated tiling regions. These regions show strong association and significant overlap with Sheffield_dnase, ucsc_features, codex, cistrome_epigenome, encode_tfbe, and encode_segmentation as indicated by the large odds ration values and the higher q−value. LOLA reference databases collections are shown on the right side of the plot with color coding.](genes-11-00034-g007){#genes-11-00034-f007}

![Bar plots of LOLA enrichment analysis showing the log-odds ratios of the 1000 most hypermethylated tiling regions. Terms that exhibit statistical significance (*p*-value \< 0.01) are shown. For encode_tfbs, c-Fos, STAT3, and c-Myc are among the top enriched terms showing large odds ratio values. Fibroblast cells, epithelial cells, muscle tissue, and skin tissue were among the most enriched cell and tissue types. Coloring of the bars reflects the putative targets of the terms.](genes-11-00034-g008){#genes-11-00034-f008}

![Bar plots of LOLA enrichment analysis showing log-odds ratios of the 1000 most hypomethylated tiling regions. Terms that exhibit statistical significance (*p*-value \< 0.01) are shown. The most enriched terms include Dnase weak-NHDF, Dnase-fibrobalsts, Weak Enhancer-HUVEC, NR2F2-Endometrial Stromal Cell, AFF1-leukaemia, H3K4me1-LNCaP, and androgen receptor (AR)-abl. Coloring of the bars reflects the putative targets of the terms.](genes-11-00034-g009){#genes-11-00034-f009}

![Pathway signaling network generated from the genes located within the top 100 DM tiling regions.](genes-11-00034-g010){#genes-11-00034-f010}

genes-11-00034-t001_Table 1

###### 

Top-ranking 100 differentially methylated genes in warts (W) compared to normal skin (NS).

  Gene                           Category                                   Chromosome   Start       End         Mean.mean β Value (NS)   Mean.mean β Value (W)   Mean.mean β Value Difference (W-NS)   Mean.mean. quot.log2   Comb.p.val        Comb.p.adj.fdr    Combined Rank
  ------------------------------ ------------------------------------------ ------------ ----------- ----------- ------------------------ ----------------------- ------------------------------------- ---------------------- ----------------- ----------------- ---------------
                                                                            10           104555001   104560000   0.113                    0.585                   0.472                                 2.275                  6.818 × 10^−16^   8.614 × 10^−11^   8
  *AZIN1-AS1*                    RNA gene (ncRNA)                           8            102975001   102980000   0.157                    0.603                   0.446                                 1.878                  2.736 × 10^−14^   4.816 × 10^−10^   32
  *EXOC4*                        Protein coding                             7            133390001   133395000   0.642                    0.134                   −0.509                                −2.184                 2.139 × 10^−13^   1.386 × 10^−9^    39
                                                                            10           4280001     4285000     0.125                    0.538                   0.412                                 2.031                  6.565 × 10^−15^   2.074 × 10^−10^   48
  *KCNU1*                        Protein coding                             8            36840001    36845000    0.583                    0.147                   −0.436                                −1.914                 9.147 × 10^−13^   3.350 × 10^−9^    69
  *SVIL2P*                       Pseudogene                                 10           30675001    30680000    0.617                    0.163                   −0.454                                −1.859                 1.342 × 10^−12^   4.403 × 10^−9^    77
  *RTN1*                         Protein coding                             14           59720001    59725000    0.151                    0.538                   0.387                                 1.768                  2.738 × 10^−15^   1.730 × 10^−10^   95
                                                                            4            62330001    62335000    0.561                    0.118                   −0.443                                −2.153                 2.391 × 10^−12^   5.796 × 10^−9^    104
  *TBC1D22A*                     Protein coding                             22           47045001    47050000    0.098                    0.479                   0.381                                 2.180                  3.913 × 10^−15^   1.732 x 10^−10^   110
  *PIWIL4, AP000943.3*           Protein coding, RNA gene                   11           94610001    94615000    0.609                    0.162                   −0.446                                −1.843                 3.742 × 10^−12^   7.253 × 10^−9^    130
  *LINC02008*                    RNA gene (ncRNA)                           3            82205001    82210000    0.524                    0.137                   −0.387                                −1.863                 3.998 × 10^−12^   7.488 10^−9^      134
  *LGI1*                         Protein coding                             10           93770001    93775000    0.514                    0.135                   −0.379                                −1.856                 4.742 × 10^−12^   8.207 × 10^−9^    146
  *VPS16, PTPRA*                 Protein coding                             20           2865001     2870000     0.499                    0.134                   −0.364                                −1.819                 5.040 × 10^−13^   2.318 × 10^−9^    151
                                                                            5            115915001   115920000   0.513                    0.132                   −0.381                                −1.879                 6.570 × 10^−12^   9.941 × 10^−9^    167
  *DPCD*                         Protein coding                             10           101590001   101595000   0.579                    0.170                   −0.409                                −1.758                 6.785 × 10^−12^   1.005 × 10^−8^    170
                                                                            12           105855001   105860000   0.497                    0.126                   −0.370                                −1.893                 6.837 × 10^−12^   1.005 × 10^−8^    171
  *MGC27382*                     RNA gene (ncRNA)                           1            78295001    78300000    0.185                    0.586                   0.402                                 1.615                  1.534 × 10^−13^   1.211 × 10^−9^    177
  *IRF2*                         Protein coding                             4            184410001   184415000   0.483                    0.125                   −0.357                                −1.864                 4.053 × 10^−12^   7.531 × 10^−9^    182
  *SLC22A16*                     Protein coding                             6            110460001   110465000   0.475                    0.118                   −0.357                                −1.916                 2.021 × 10^−12^   5.283 × 10^−9^    186
                                                                            2            152330001   152335000   0.171                    0.536                   0.365                                 1.593                  7.112 × 10^−14^   8.169 × 10^−10^   195
  *CAB39L*                       Protein coding                             13           49365001    49370000    0.563                    0.095                   −0.467                                −2.441                 9.568 × 10^−12^   1.229 × 10^−8^    195
                                                                            2            220830001   220835000   0.650                    0.197                   −0.454                                −1.677                 1.176 × 10^−11^   1.363 × 10^−8^    218
                                                                            3            24080001    24085000    0.218                    0.684                   0.466                                 1.607                  1.218 × 10^−11^   1.406 × 10^−8^    219
  *NRG1*                         Protein coding                             8            32280001    32285000    0.171                    0.530                   0.360                                 1.580                  1.266 × 10^−11^   1.434 × 10^−8^    223
  *FAAHP1*                       Pseudogene                                 1            46465001    46470000    0.507                    0.159                   −0.348                                −1.613                 5.414 × 10^−12^   9.001 × 10^−9^    228
  *L3HYPDH, AL121694.1, JKAMP*   Protein coding, RNA gene, Protein coding   14           59480001    59485000    0.494                    0.139                   −0.355                                −1.756                 1.410 × 10^−11^   1.543 × 10^−8^    231
  *BPIFA4P*                      Pseudogene                                 20           33205001    33210000    0.785                    0.243                   −0.543                                −1.655                 1.472 × 10^−11^   1.569 × 10^−8^    237
  *CUZD1*                        Protein coding                             10           122835001   122840000   0.124                    0.469                   0.346                                 1.843                  1.675 × 10^−12^   4.809 × 10^−9^    242
  *LINC02241*                    RNA gene (ncRNA)                           5            20675001    20680000    0.506                    0.148                   −0.358                                −1.707                 1.547 × 10^−11^   1.608 × 10^−8^    243
                                                                            6            14050001    14055000    0.530                    0.136                   −0.394                                −1.889                 1.587 × 10^−11^   1.630 × 10^−8^    246
  *FER1L6, FER1L6-AS1*           Protein coding, RNA gene (ncRNA)           8            123990001   123995000   0.503                    0.160                   −0.344                                −1.596                 2.420 × 10^−12^   5.796 × 10^−9^    251
  *DDAH1, AC092807.3*            Protein coding, RNA gene                   1            85555001    85560000    0.549                    0.143                   −0.407                                −1.873                 1.752 × 10^−11^   1.710 × 10^−8^    258
                                                                            15           86070001    86075000    0.172                    0.515                   0.342                                 1.526                  8.259 × 10^−12^   1.116 × 10^−8^    266
                                                                            1            232655001   232660000   0.421                    0.080                   −0.341                                −2.263                 5.031 × 10^−12^   8.532 × 10^−9^    269
  *KLHL7*                        Protein coding                             7            23135001    23140000    0.525                    0.150                   −0.375                                −1.738                 1.938 × 10^−11^   1.814 × 10^−8^    270
  *TANGO6*                       Protein coding                             16           69070001    69075000    0.614                    0.208                   −0.406                                −1.519                 4.213 × 10^−14^   6.654 × 10^−10^   273
  *LINC01090*                    RNA gene (ncRNA)                           2            188220001   188225000   0.569                    0.193                   −0.376                                −1.510                 3.271 × 10^−12^   6.621 × 10^−9^    285
  *CASC2*                        RNA gene (ncRNA)                           10           118190001   118195000   0.485                    0.142                   −0.343                                −1.700                 2.307 × 10^−11^   1.971 × 10^−8^    295
                                                                            20           5040001     5045000     0.685                    0.236                   −0.450                                −1.500                 2.152 × 10^−11^   1.915 × 10^−8^    298
  *ARHGAP24*                     Protein coding                             4            85610001    85615000    0.500                    0.153                   −0.346                                −1.640                 2.522 × 10^−11^   2.096 × 10^−8^    304
  *CCR3*                         Protein coding                             3            46235001    46240000    0.542                    0.188                   −0.354                                −1.480                 8.227 × 10^−12^   1.116 × 10^−8^    322
  *THOC2*                        Protein coding                             X            123630001   123635000   0.652                    0.208                   −0.444                                −1.603                 3.058 × 10^−11^   2.321 × 10^−8^    333
  *FBXL17*                       Protein coding                             5            108135001   108140000   0.717                    0.221                   −0.497                                −1.658                 3.152 × 10^−11^   2.351 × 10^−8^    338
  *VPS13D, SNORA59A*             Protein coding, RNA gene (snoRNA)          1            12505001    12510000    0.190                    0.517                   0.328                                 1.576                  2.859 × 10^−14^   4.816 × 10^−10^   346
                                                                            5            141905001   141910000   0.491                    0.166                   −0.326                                −1.513                 3.232 × 10^−12^   6.621 × 10^−9^    357
                                                                            1            173115001   173120000   0.491                    0.164                   −0.327                                −1.523                 3.557 × 10^−11^   2.495 × 10^−8^    358
                                                                            5            57295001    57300000    0.576                    0.174                   −0.401                                −1.669                 3.617 × 10^−11^   2.525 × 10^−8^    362
  *ERBIN*                        Protein coding                             5            66010001    66015000    0.495                    0.161                   −0.334                                −1.563                 3.822 × 10^−11^   2.592 × 10^−8^    371
  *AC105758.1*                   Pseudogene                                 4            126105001   126110000   0.468                    0.145                   −0.324                                −1.628                 1.828 × 10^−11^   1.743 × 10^−8^    374
                                                                            17           25850001    25855000    0.206                    0.573                   0.367                                 1.431                  1.336 × 10^−13^   1.206 × 10^−9^    410
  *FAM76B*                       Protein coding                             11           95775001    95780000    0.226                    0.623                   0.397                                 1.429                  2.820 × 10^−13^   1.738 × 10^−9^    415
                                                                            1            209490001   209495000   0.635                    0.201                   −0.434                                −1.614                 5.365 × 10^−11^   3.172 × 10^−8^    426
  *EFCAB13, AC040934.1*          Protein coding, RNA gene                   17           47415001    47420000    0.092                    0.410                   0.317                                 2.034                  9.620 × 10^−12^   1.229 × 10^−8^    430
  *PHC2*                         Protein coding                             1            33405001    33410000    0.515                    0.186                   −0.329                                −1.422                 2.189 10^−12^     5.477 × 10^−9^    435
  *AGO4*                         Protein coding                             1            35835001    35840000    0.203                    0.559                   0.356                                 1.418                  4.086 × 10^−11^   2.675 × 10^−8^    443
  *AC079160.1*                   RNA gene                                   4            84235001    84240000    0.503                    0.163                   −0.341                                −1.572                 5.979 × 10^−11^   3.410 × 10^−8^    443
  *PAK4*                         Protein coding                             19           39160001    39165000    0.180                    0.498                   0.318                                 1.417                  1.745 × 10^−14^   4.009 × 10^−10^   448
  *AP003100.2*                   RNA gene                                   11           112700001   112705000   0.510                    0.185                   −0.325                                −1.413                 2.551 × 10^−11^   2.114 × 10^−8^    456
  *CLEC4C*                       Protein coding                             12           7750001     7755000     0.433                    0.119                   −0.314                                −1.777                 2.365 × 10^−11^   1.998 × 10^−8^    456
                                                                            12           92635001    92640000    0.222                    0.614                   0.392                                 1.429                  6.703 × 10^−11^   3.642 × 10^−8^    465
                                                                            6            164210001   164215000   0.475                    0.137                   −0.337                                −1.717                 6.867 × 10^−11^   3.716 × 10^−8^    467
  *METTL15*                      Protein coding                             11           28160001    28165000    0.724                    0.267                   −0.456                                −1.404                 3.133 × 10^−13^   1.885 × 10^−9^    477
  *RTKN2*                        Protein coding                             10           62205001    62210000    0.158                    0.474                   0.315                                 1.522                  7.807 × 10^−11^   4.119 × 10^−8^    479
  *LINC00824*                    RNA gene (ncRNA)                           8            128535001   128540000   0.439                    0.127                   −0.312                                −1.709                 3.343 × 10^−12^   6.660 × 10^−9^    482
  *MSANTD3-TMEFF1, TMEFF1*       Protein coding                             9            100550001   100555000   0.564                    0.209                   −0.355                                −1.392                 1.378 × 10^−12^   4.408 × 10^−9^    500
  *MBNL1*                        Protein coding                             3            152310001   152315000   0.121                    0.447                   0.326                                 1.804                  9.367 × 10^−11^   4.669 × 10^−8^    507
  *AC092106.2*                   Pseudogene                                 2            106205001   106210000   0.486                    0.170                   −0.316                                −1.461                 9.531 × 10^−11^   4.677 × 10^−8^    515
                                                                            13           106570001   106575000   0.424                    0.113                   −0.311                                −1.822                 9.607 × 10^−11^   4.705 × 10^−8^    516
  *FKBP5*                        Protein coding                             6            35690001    35695000    0.219                    0.605                   0.386                                 1.424                  1.015 × 10^−10^   4.858 × 10^−8^    528
  *ARFGAP3*                      Protein coding                             22           42805001    42810000    0.243                    0.647                   0.405                                 1.379                  2.067 × 10^−13^   1.386 × 10^−9^    529
  *DDAH1, AL078459.1*            Protein coding, RNA gene                   1            85370001    85375000    0.456                    0.150                   −0.306                                −1.540                 1.696 × 10^−11^   1.689 × 10^−8^    540
  *HDAC2*                        Protein coding                             6            113930001   113935000   0.241                    0.640                   0.398                                 1.371                  1.476 × 10^−13^   1.211 × 10^−9^    545
                                                                            10           4925001     4930000     0.427                    0.123                   −0.304                                −1.719                 3.638 × 10^−11^   2.533 × 10^−8^    555
  *AC011287.1*                   RNA gene                                   7            13235001    13240000    0.429                    0.125                   −0.304                                −1.699                 1.148 × 10^−10^   5.173 × 10^−8^    562
                                                                            8            92330001    92335000    0.476                    0.164                   −0.312                                −1.479                 1.154 × 10^−10^   5.173 × 10^−8^    564
  *CD96*                         Protein coding                             3            111620001   111625000   0.468                    0.153                   −0.316                                −1.557                 1.178 × 10^−10^   5.233 × 10^−8^    569
                                                                            8            8945001     8950000     0.456                    0.143                   −0.313                                −1.607                 1.183 × 10^−10^   5.233 × 10^−8^    571
  *MRPL33, BABAM2*               Protein coding                             2            27980001    27985000    0.467                    0.165                   −0.302                                −1.449                 1.378 × 10^−11^   1.514 × 10^−8^    573
  *TEX15*                        Protein coding                             8            30855001    30860000    0.561                    0.212                   −0.349                                −1.361                 1.055 x 10^−10^   4.956 x 10^−8^    574
                                                                            14           51125001    51130000    0.116                    0.417                   0.301                                 1.763                  3.558 × 10^−11^   2.495 × 10^−8^    581
  *AC008676.3, ADAM19*           Protein coding                             5            157425001   157430000   0.598                    0.160                   −0.437                                −1.835                 1.322 × 10^−10^   5.680 × 10^−8^    588
                                                                            4            184025001   184030000   0.433                    0.133                   −0.300                                −1.634                 8.532 × 10^−11^   4.382 × 10^−8^    590
  *COG2*                         Protein coding                             1            230645001   230650000   0.409                    0.087                   −0.323                                −2.117                 1.358 × 10^−10^   5.756 × 10^−8^    596
  *ATF2*                         Protein coding                             2            175125001   175130000   0.414                    0.115                   −0.300                                −1.767                 4.230 × 10^−12^   7.608 × 10^−9^    599
                                                                            7            134975001   134980000   0.406                    0.107                   −0.298                                −1.825                 5.356 × 10^−11^   3.172 × 10^−8^    610
  *LINC01320*                    RNA gene (ncRNA)                           2            34325001    34330000    0.525                    0.156                   −0.369                                −1.691                 1.510 × 10^−10^   6.206 × 10^−8^    615
  *ADAMTS6*                                                                 5            65405001    65410000    0.443                    0.134                   −0.309                                −1.654                 1.531 × 10^−10^   6.251 × 10^−8^    619
  *AC013356.1*                   Pseudogene                                 15           40480001    40485000    0.432                    0.129                   −0.303                                −1.667                 1.554 × 10^−10^   6.314 × 10^−8^    621
  *AL050403.2*                   RNA gene                                   20           10735001    10740000    0.554                    0.171                   −0.383                                −1.640                 1.555 × 10^−10^   6.314 × 10^−8^    622
  *MANSC1*                       Protein coding                             12           12345001    12350000    0.482                    0.172                   −0.310                                −1.434                 1.571 × 10^−10^   6.354 × 10^−8^    625
  *UAP1*                         Protein coding                             1            162575001   162580000   0.410                    0.114                   −0.296                                −1.762                 6.338 × 10^−12^   9.887 × 10^−9^    628
  *AP000311.1, ITSN1*            Protein coding                             21           33710001    33715000    0.408                    0.112                   −0.296                                −1.773                 9.062 × 10^−11^   4.580 × 10^−8^    630
  *NRG1*                         Protein coding                             8            32550001    32555000    0.421                    0.125                   −0.296                                −1.675                 1.996 × 10^−12^   5.283 × 10^−9^    632
  *LINC01470*                    RNA gene (ncRNA)                           5            152940001   152945000   0.483                    0.160                   −0.323                                −1.538                 1.668 × 10^−10^   6.602 × 10^−8^    638
  *FOXN3*                        Protein coding                             14           89165001    89170000    0.566                    0.208                   −0.359                                −1.404                 1.672 × 10^−10^   6.602 × 10^−8^    640
  *GPM6B*                        Protein coding                             X            13840001    13845000    0.528                    0.152                   −0.376                                −1.730                 1.729 × 10^−10^   6.795 × 10^−8^    643
                                                                            7            158605001   158610000   0.200                    0.519                   0.319                                 1.333                  3.342 × 10^−11^   2.427 × 10^−8^    651
                                                                            12           59475001    59480000    0.273                    0.687                   0.414                                 1.332                  1.031 × 10^−14^   2.605 × 10^−10^   653
  *FOXN3*                        Protein coding                             14           89345001    89350000    0.479                    0.131                   −0.348                                −1.796                 1.893 × 10^−10^   7.201 × 10^−8^    664
  *LINC01098*                    RNA gene (ncRNA)                           4            177930001   177935000   0.609                    0.212                   −0.397                                −1.478                 1.914 × 10^−10^   7.261 × 10^−8^    666
